IOL CHEMICALS & PHARM. | LINK PHARMA | IOL CHEMICALS & PHARM./ LINK PHARMA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.7 | -11.0 | - | View Chart |
P/BV | x | 1.6 | 1.3 | 116.9% | View Chart |
Dividend Yield | % | 1.0 | 0.0 | - |
IOL CHEMICALS & PHARM. LINK PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
LINK PHARMA Mar-23 |
IOL CHEMICALS & PHARM./ LINK PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 75 | 715.6% | |
Low | Rs | 272 | 35 | 776.6% | |
Sales per share (Unadj.) | Rs | 377.6 | 87.3 | 432.6% | |
Earnings per share (Unadj.) | Rs | 23.7 | 1.5 | 1,609.0% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 3.6 | 888.6% | |
Dividends per share (Unadj.) | Rs | 4.00 | 0 | - | |
Avg Dividend yield | % | 1.0 | 0 | - | |
Book value per share (Unadj.) | Rs | 256.8 | 33.9 | 758.2% | |
Shares outstanding (eoy) | m | 58.71 | 4.44 | 1,322.3% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 0.6 | 169.9% | |
Avg P/E ratio | x | 17.1 | 37.3 | 45.7% | |
P/CF ratio (eoy) | x | 12.8 | 15.5 | 82.7% | |
Price / Book Value ratio | x | 1.6 | 1.6 | 96.9% | |
Dividend payout | % | 16.9 | 0 | - | |
Avg Mkt Cap | Rs m | 23,743 | 244 | 9,717.2% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 57 | 2,956.8% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 388 | 5,720.4% | |
Other income | Rs m | 256 | 3 | 9,850.0% | |
Total revenues | Rs m | 22,427 | 390 | 5,748.1% | |
Gross profit | Rs m | 2,257 | 23 | 9,765.0% | |
Depreciation | Rs m | 462 | 9 | 5,001.1% | |
Interest | Rs m | 165 | 8 | 2,164.3% | |
Profit before tax | Rs m | 1,887 | 9 | 21,292.3% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 2 | 21,340.5% | |
Profit after tax | Rs m | 1,391 | 7 | 21,275.2% | |
Gross profit margin | % | 10.2 | 6.0 | 170.7% | |
Effective tax rate | % | 26.2 | 26.2 | 100.2% | |
Net profit margin | % | 6.3 | 1.7 | 371.8% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 175 | 5,508.3% | |
Current liabilities | Rs m | 5,025 | 145 | 3,462.3% | |
Net working cap to sales | % | 20.9 | 7.8 | 267.3% | |
Current ratio | x | 1.9 | 1.2 | 159.1% | |
Inventory Days | Days | 43 | 56 | 77.8% | |
Debtors Days | Days | 8 | 342 | 2.4% | |
Net fixed assets | Rs m | 11,017 | 149 | 7,389.8% | |
Share capital | Rs m | 587 | 44 | 1,322.0% | |
"Free" reserves | Rs m | 14,490 | 106 | 13,671.2% | |
Net worth | Rs m | 15,077 | 150 | 10,025.4% | |
Long term debt | Rs m | 0 | 20 | 0.0% | |
Total assets | Rs m | 20,684 | 325 | 6,372.5% | |
Interest coverage | x | 12.5 | 2.2 | 575.4% | |
Debt to equity ratio | x | 0 | 0.1 | 0.0% | |
Sales to assets ratio | x | 1.1 | 1.2 | 89.8% | |
Return on assets | % | 7.5 | 4.4 | 172.5% | |
Return on equity | % | 9.2 | 4.4 | 212.1% | |
Return on capital | % | 13.6 | 9.7 | 140.6% | |
Exports to sales | % | 26.7 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | 5,930 | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 5,930 | 0 | - | |
Fx outflow | Rs m | 6,052 | 0 | - | |
Net fx | Rs m | -122 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | -17 | -7,162.9% | |
From Investments | Rs m | -1,200 | -1 | 160,000.0% | |
From Financial Activity | Rs m | -41 | 16 | -255.6% | |
Net Cashflow | Rs m | -18 | -2 | 1,057.5% |
Indian Promoters | % | 48.2 | 51.5 | 93.6% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 0.0 | 8,500.0% | |
FIIs | % | 1.4 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 48.5 | 106.8% | |
Shareholders | 130,003 | 6,200 | 2,096.8% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | LINK PHARMA | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.56% | 2.02% | 0.97% |
1-Month | 5.64% | 7.37% | 2.08% |
1-Year | -1.14% | 14.42% | 55.37% |
3-Year CAGR | -12.91% | 4.35% | 15.04% |
5-Year CAGR | 16.34% | 16.47% | 19.56% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the LINK PHARMA share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of LINK PHARMA the stake stands at 51.5%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of LINK PHARMA.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
LINK PHARMA paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of LINK PHARMA.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets continued the momentum as the session progressed and ended the higher.